Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Recruiting · NCT04486833 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT04486833 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Genprex, Inc. | 2 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Carle Cancer Institute | Urbana | United States | 3 |
| Gabrail Cancer Center Research | Canton | United States | 26 |
| Markey Cancer Center | Lexington | United States | 6 |
| Maryland Oncology Hematology | Rockville | United States | 3 |
| Millennium Oncology | Houston | United States | 1 |
| Rocky Mountain Cancer Centers | Lone Tree | United States | 11 |
| The Valley Hospital - Luckow Pavilion | Paramus | United States | 47 |
| Valkyrie Clinical Trials | Los Angeles | United States | 47 |
| Virginia Cancer Specialists | Fairfax | United States | 109 |
| Virginia Oncology Associates | Norfolk | United States | 73 |